breast cancer and semaglutide For years, researchers have known that obesity is associated with an increased risk of developing dying from several cancers, including cancer. At ASCO 2026, new studies examining GLP-1 receptor agonists GLP-1 medications may offer benefits

Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility

Injecting into muscle causes faster, unpredictable absorption, reduced efficacy, and greater pain

Document mood symptoms, timing of medication doses, food intake, blood glucose readings, and other relevant factors

The biological mechanisms responsible for BPC-157 effects center on nitric oxide signaling, growth factor interaction, and multi-pathway cellular activation

It's wellness, on demand

In clinical practice, Wegovys place in therapy is likely as: A foundational pharmacologic option for patients with obesity or overweight and established cardiovascular disease who remain at high residual risk despite standard therapies